Catharina H M J Van Elssen1, Mohammad Rashidian2,3, Vladimir Vrbanac4, Kai W Wucherpfennig5,6, Zeina El Habre7, Jana Sticht7, Christian Freund7, Johanne T Jacobsen2,3,8, Juanjo Cragnolini2,3, Jessica Ingram2,3, Loes Plaisier9, Eric Spierings9, Andrew M Tager4,10, Hidde L Ploegh11,3. 1. Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands. 2. Whitehead Institute for Biomedical Research, Cambridge, Massachusetts. 3. Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts. 4. Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts. 5. Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts. 6. Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. 7. Protein Engineering Group, Leibniz Institute for Molecular Pharmacology and Freie Universität Berlin, Berlin, Germany. 8. Center for Immune Regulation, Oslo University Hospital, University of Oslo, Oslo, Norway. 9. Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; and. 10. Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Charlestown, Massachusetts. 11. Whitehead Institute for Biomedical Research, Cambridge, Massachusetts ploegh@wi.mit.edu.
Abstract
The immune system plays a crucial role in many diseases. Activation or suppression of immunity is often related to clinical outcome. Methods to explore the dynamics of immune responses are important to elucidate their role in conditions characterized by inflammation, such as infectious disease, cancer, or autoimmunity. Immuno-PET is a noninvasive method by which disease and immune cell infiltration can be explored simultaneously. Using radiolabeled antibodies or fragments derived from them, it is possible to image disease-specific antigens and immune cell subsets. Methods: We developed a method to noninvasively image human immune responses in a relevant humanized mouse model. We generated a camelid-derived single-domain antibody specific for human class II major histocompatibility complex products and used it to noninvasively image human immune cell reconstitution in nonobese diabetic severe combined immune deficiency γ-/- mice reconstituted with human fetal thymus, liver, and liver-derived hematopoietic stem cells (BLT mice). Results: We showed imaging of infiltrating immunocytes in BLT mice that spontaneously developed a graft-versus-host-like condition, characterized by alopecia and blepharitis. In diseased animals, we showed an increased PET signal in the liver, attributable to infiltration of activated class II major histocompatibility complex+ T cells. Conclusion: Noninvasive imaging of immune infiltration and activation could thus be of importance for diagnosis and evaluation of treatment of graft-versus-host disease and holds promise for other diseases characterized by inflammation.
The immune system plays a crucial role in many diseases. Activation or suppression of immunity is often related to clinical outcome. Methods to explore the dynamics of immune responses are important to elucidate their role in conditions characterized by inflammation, such as infectious disease, cancer, or autoimmunity. Immuno-PET is a noninvasive method by which disease and immune cell infiltration can be explored simultaneously. Using radiolabeled antibodies or fragments derived from them, it is possible to image disease-specific antigens and immune cell subsets. Methods: We developed a method to noninvasively image human immune responses in a relevant humanized mouse model. We generated a camelid-derived single-domain antibody specific for human class II major histocompatibility complex products and used it to noninvasively image human immune cell reconstitution in nonobese diabetic severe combined immune deficiency γ-/- mice reconstituted with human fetal thymus, liver, and liver-derived hematopoietic stem cells (BLT mice). Results: We showed imaging of infiltrating immunocytes in BLT mice that spontaneously developed a graft-versus-host-like condition, characterized by alopecia and blepharitis. In diseased animals, we showed an increased PET signal in the liver, attributable to infiltration of activated class II major histocompatibility complex+ T cells. Conclusion: Noninvasive imaging of immune infiltration and activation could thus be of importance for diagnosis and evaluation of treatment of graft-versus-host disease and holds promise for other diseases characterized by inflammation.
Authors: Eun Mi Hur; Sonal N Patel; Saki Shimizu; Dinesh S Rao; Priyanthi N P Gnanapragasam; Dong Sung An; Lili Yang; David Baltimore Journal: Blood Date: 2012-10-11 Impact factor: 22.113
Authors: Richard Tavaré; Helena Escuin-Ordinas; Stephen Mok; Melissa N McCracken; Kirstin A Zettlitz; Felix B Salazar; Owen N Witte; Antoni Ribas; Anna M Wu Journal: Cancer Res Date: 2015-11-16 Impact factor: 12.701
Authors: Els Pardon; Toon Laeremans; Sarah Triest; Søren G F Rasmussen; Alexandre Wohlkönig; Armin Ruf; Serge Muyldermans; Wim G J Hol; Brian K Kobilka; Jan Steyaert Journal: Nat Protoc Date: 2014-02-27 Impact factor: 13.491
Authors: Joao N Duarte; Juan J Cragnolini; Lee Kim Swee; Angelina M Bilate; Justin Bader; Jessica R Ingram; Ali Rashidfarrokhi; Tao Fang; Ariën Schiepers; Leo Hanke; Hidde L Ploegh Journal: J Immunol Date: 2016-11-07 Impact factor: 5.422
Authors: Anne-Kathrin Anders; Melissa J Call; Monika-Sarah E D Schulze; Kevin D Fowler; David A Schubert; Nilufer P Seth; Eric J Sundberg; Kai W Wucherpfennig Journal: Nat Immunol Date: 2010-12-05 Impact factor: 25.606
Authors: Mohammad Rashidian; Edmund J Keliher; Angelina M Bilate; Joao N Duarte; Gregory R Wojtkiewicz; Johanne Tracey Jacobsen; Juanjo Cragnolini; Lee Kim Swee; Gabriel D Victora; Ralph Weissleder; Hidde L Ploegh Journal: Proc Natl Acad Sci U S A Date: 2015-04-20 Impact factor: 11.205
Authors: Matthew B Greenblatt; Vladimir Vrbanac; Vladimir Vbranac; Trevor Tivey; Kelly Tsang; Andrew M Tager; Antonios O Aliprantis Journal: PLoS One Date: 2012-09-05 Impact factor: 3.240
Authors: Israt S Alam; Federico Simonetta; Lukas Scheller; Aaron T Mayer; Robert Negrin; Sanjiv S Gambhir; Surya Murty; Ophir Vermesh; Tomomi W Nobashi; Juliane K Lohmeyer; Toshihito Hirai; Jeanette Baker; Kenneth H Lau Journal: Cancer Res Date: 2020-09-08 Impact factor: 12.701
Authors: Nairo Brilhante-da-Silva; Rosa Maria de Oliveira Sousa; Andrelisse Arruda; Eliza Lima Dos Santos; Anna Carolina Machado Marinho; Rodrigo Guerino Stabeli; Carla Freire Celedonio Fernandes; Soraya Dos Santos Pereira Journal: Mol Diagn Ther Date: 2021-06-19 Impact factor: 4.074
Authors: Thibault Harmand; Liyan Y Smeding; Novalia Pishesha; Weiyi Ma; Leif S Ludwig; Robine Janssen; Ashraful Islam; Yushu J Xie; Tao Fang; Nicholas McCaul; William Pinney; Harun R Sugito; Martin A Rossotti; Gualberto Gonzalez-Sapienza; Hidde L Ploegh Journal: Nat Biomed Eng Date: 2021-06-14 Impact factor: 25.671